Terms: = Lung cancer AND ETV4, PEA3, 2118, ENSG00000175832, E1AF, E1A-F, PEAS3
57 results:
1. Cytohistological findings and diagnostic challenges in rare pediatric pulmonary mesenchymal malignancies: A report of two cases.
Balaji K; Siddique SS; Khurana U; Goel G; Tandon A; Joshi D; Chaudhary N; Khurana AK; Goyal A
Diagn Cytopathol; 2024 Apr; 52(4):E88-E94. PubMed ID: 38235937
[TBL] [Abstract] [Full Text] [Related]
2. The Mediating Role of miR-451/etv4/MMP13 Signaling Axis on Epithelialmesenchymal Transition in Promoting Non-small Cell lung cancer Progression.
Qian XJ; Wang JW; Liu JB; Yu X
Curr Mol Pharmacol; 2024; 17():e210723218988. PubMed ID: 37489792
[TBL] [Abstract] [Full Text] [Related]
3. HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under etv4 targeting-induced low-lactate stress in non-small cell lung cancer.
Liu B; Zhang J; Meng X; Xie SM; Liu F; Chen H; Yao D; Li M; Guo M; Shen H; Zhang X; Xing L
Oncogene; 2023 Apr; 42(15):1181-1195. PubMed ID: 36823378
[TBL] [Abstract] [Full Text] [Related]
4. Financial Toxicities Persist for cancer Survivors Irrespective of Current cancer Status: An Analysis of Medical Expenditure Panel Survey.
Karim MA; Talluri R; Shastri SS; Kum HC; Shete S
Cancer Res Commun; 2022 Oct; 2(10):1119-1128. PubMed ID: 36531523
[TBL] [Abstract] [Full Text] [Related]
5. Targeting pea3 transcription factors to mitigate small cell lung cancer progression.
Shia DW; Choi W; Vijayaraj P; Vuong V; Sandlin JM; Lu MM; Aziz A; Marin C; Aros CJ; Sen C; Durra A; Lund AJ; Purkayastha A; Rickabaugh TM; Graeber TG; Gomperts BN
Oncogene; 2023 Feb; 42(6):434-448. PubMed ID: 36509998
[TBL] [Abstract] [Full Text] [Related]
6. CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis.
Tian T; Lu Y; Lin J; Chen M; Qiu H; Zhu W; Sun H; Huang J; Yang H; Deng W
Redox Biol; 2022 Dec; 58():102544. PubMed ID: 36427397
[TBL] [Abstract] [Full Text] [Related]
7. Effects of Acid-Reducing Agents on the Pharmacokinetics of Lazertinib in Patients with EGFR Mutation-Positive Advanced Non-Small-Cell lung cancer.
Kim B; Lee J; Jang H; Lee N; Mehta J; Jang SB
Adv Ther; 2022 Oct; 39(10):4757-4771. PubMed ID: 35962934
[TBL] [Abstract] [Full Text] [Related]
8. Single-Cell Transcriptomics of Immune Cells Reveal Diversity and Exhaustion Signatures in Non-Small-Cell lung cancer.
Zhao Y; Zhang Q; Tu K; Chen Y; Peng Y; Ni Y; Zhu G; Cheng C; Li Y; Xiao X; Yu C; Lu K; Chen Y; Li C; Tang J; Wang G; Luo W; Zhang W; Che G; Li W; Wang Z; Xie D
Front Immunol; 2022; 13():854724. PubMed ID: 35874785
[TBL] [Abstract] [Full Text] [Related]
9. CIC-DUX4 sarcomas.
Brahmi M; Vanacker H; Macagno N; Tirode F; Dufresne A
Curr Opin Oncol; 2022 Jul; 34(4):342-347. PubMed ID: 35730520
[TBL] [Abstract] [Full Text] [Related]
10. USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction.
Kim MJ; Min Y; Jeong SK; Son J; Kim JY; Lee JS; Kim DH; Lee JS; Chun E; Lee KY
Cell Death Dis; 2022 Apr; 13(4):348. PubMed ID: 35422093
[TBL] [Abstract] [Full Text] [Related]
11. etv4 mediated lncRNA C2CD4D-AS1 overexpression contributes to the malignant phenotype of lung adenocarcinoma cells via miR-3681-3p/NEK2 axis.
Wang B; Cai Y; Li X; Kong Y; Fu H; Zhou J
Cell Cycle; 2021 Dec; 20(24):2607-2618. PubMed ID: 34850664
[TBL] [Abstract] [Full Text] [Related]
12. Sustained-hepatic arterial infusion of oxaliplatin: pharmacokinetic advantages over hepatic arterial infusion using a preclinical animal tumour model.
Deschamps F; Tselikas L; Tasaki M; Motoyama S; Isoardo T; Ducreux M; Paunovic D; Moine L; de Baere T
Drug Deliv Transl Res; 2021 Oct; 11(5):2144-2150. PubMed ID: 33432522
[TBL] [Abstract] [Full Text] [Related]
13. An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis.
Hight SK; Mootz A; Kollipara RK; McMillan E; Yenerall P; Otaki Y; Li LS; Avila K; Peyton M; Rodriguez-Canales J; Mino B; Villalobos P; Girard L; Dospoy P; Larsen J; White MA; Heymach JV; Wistuba II; Kittler R; Minna JD
Neoplasia; 2020 Aug; 22(8):294-310. PubMed ID: 32512502
[TBL] [Abstract] [Full Text] [Related]
14. etv4 is a theranostic target in clear cell renal cell carcinoma that promotes metastasis by activating the pro-metastatic gene FOSL1 in a PI3K-AKT dependent manner.
Xu L; Hu H; Zheng LS; Wang MY; Mei Y; Peng LX; Qiang YY; Li CZ; Meng DF; Wang MD; Liu ZJ; Li XJ; Huang BJ; Qian CN
Cancer Lett; 2020 Jul; 482():74-89. PubMed ID: 32305558
[TBL] [Abstract] [Full Text] [Related]
15. etv4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally.
Wang Y; Ding X; Liu B; Li M; Chang Y; Shen H; Xie SM; Xing L; Li Y
Mol Carcinog; 2020 Jan; 59(1):73-86. PubMed ID: 31670855
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic Accuracy of Percutaneous Transthoracic Needle lung Biopsies: A Multicenter Study.
Lee KH; Lim KY; Suh YJ; Hur J; Han DH; Kang MJ; Choo JY; Kim C; Kim JI; Yoon SH; Lee W; Park CM
Korean J Radiol; 2019 Aug; 20(8):1300-1310. PubMed ID: 31339018
[TBL] [Abstract] [Full Text] [Related]
17. etv4 promotes proliferation and invasion of lung adenocarcinoma by transcriptionally upregulating MSI2.
Cheng T; Zhang Z; Cheng Y; Zhang J; Tang J; Tan Z; Liang Z; Chen T; Liu Z; Li J; Zhao J; Zhou R
Biochem Biophys Res Commun; 2019 Aug; 516(1):278-284. PubMed ID: 31253395
[TBL] [Abstract] [Full Text] [Related]
18. Critical role of the MCAM-etv4 axis triggered by extracellular S100A8/A9 in breast cancer aggressiveness.
Chen Y; Sumardika IW; Tomonobu N; Kinoshita R; Inoue Y; Iioka H; Mitsui Y; Saito K; Ruma IMW; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Futami J; Kubo M; Putranto EW; Murakami T; Liu M; Hibino T; Nishibori M; Kondo E; Toyooka S; Sakaguchi M
Neoplasia; 2019 Jul; 21(7):627-640. PubMed ID: 31100639
[TBL] [Abstract] [Full Text] [Related]
19. PBK overexpression promotes metastasis of hepatocellular carcinoma via activating etv4-uPAR signaling pathway.
Yang QX; Zhong S; He L; Jia XJ; Tang H; Cheng ST; Ren JH; Yu HB; Zhou L; Zhou HZ; Ren F; Hu ZW; Gong R; Huang AL; Chen J
Cancer Lett; 2019 Jun; 452():90-102. PubMed ID: 30914208
[TBL] [Abstract] [Full Text] [Related]
20. Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.
Chen Y; Sumardika IW; Tomonobu N; Winarsa Ruma IM; Kinoshita R; Kondo E; Inoue Y; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Liu M; Futami J; Sasai K; Katayama H; Kubo M; Putranto EW; Hibino T; Sun B; Nishibori M; Toyooka S; Sakaguchi M
Cancer Lett; 2019 Jun; 452():178-190. PubMed ID: 30904617
[TBL] [Abstract] [Full Text] [Related]
[Next]
